Timothy S. Chang, MD, PhD and Lisa L. Barnes, PhD, discuss health disparities in Alzheimer disease and related dementias and how to improve clinical outcomes for patients from underrepresented groups.
Approval of the Alzheimer medication lecanemab comes after controversial approval in 2021 of aducanumab, which met with criticism over concerns about that drug’s effectiveness, safety, pricing
Research findings support the use of vitamin D supplementation to help slow cognitive decline in Alzheimer dementia and reduce Parkinson disease symptom severity.
Recent FDA approvals include treatments for acute low back pain, postoperative nausea and vomiting, multiple myeloma, hemophilia B, and fibromyalgia pain.
Researchers investigated the efficacy of methylphenidate and behavioral parent training in improving global functioning in preschool children with attention-deficit/hyperactivity disorder.
As people living with HIV begin to age, their risk of developing HIV-associated cognitive decline increases. A specific training program to help patients with HIV with speed of processing (SOP) may help stall those effects.